A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators
Launched by UNIVERSITY OF COLORADO, DENVER · Dec 11, 2017
Trial Information
Current as of October 10, 2025
Completed
Keywords
ClinConnect Summary
The investigators propose the DECIDE-ICD trial: a type II effectiveness implementation hybrid trial of the investigators ICD PtDAs. The Investigators will use a 6-site stepped-wedge design, with implementation guided by normalization process theory® and evaluation guided by the RE-AIM framework.
The investigators aim to evaluate reach and effectiveness of the ICD PtDAs using a pragmatic, stepped-wedge design on decision quality (knowledge and value-concordance) and psychosocial outcomes.
* Hypothesis 1a: PtDAs will reach over 50% of eligible patients.
* Hypothesis 1b: ICD PtDAs will be ef...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • English-speaking (videos and surveys have only been validated in English)
- • Patients have been offered a primary prevention ICD for initial implant, reimplantation, or CRT with defibrillation
- Exclusion Criteria:
- • Prisoners
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
Daniel D Matlock, MD, MPH
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials